contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


optomed-oyj-change-in-optomeds-holding-of-treasury-10

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Optomed operates in the medical technology sector. The company conducts research and development of specialized eye cameras. Development takes place of both hardware and software that are resold under different brands. Operations are held on a global level, with the largest presence in the Nordic market. Customers consist of research institutes and hospitals. The company has its headquarters in Oulu.

At least you’d imagine the relations are in order

Northwestern Medicine, with 11 hospitals and 200 locations in the Chicago area, is currently scaling AI-based retinopathy screening across its entire clinic network and its partner network. It’s hard to say if Aurora Aeye is involved, but it would seem like a rather heavy solution (investments, space requirements, etc.) if they were to acquire tabletop cameras for every clinic.

There is, however, a hint in that picture: an older Optomed camera, the Optomed Smartscope.

And how timely, Signify Health announced something like this (likely requires an FDA-approved portable?);                   signifyhealth.com              Signify Health Adds Condition-Focused In-Home Visits    Signify Health announced the launch of condition Focused Visits to provide screenings, preventive care and tailored health education for health plan members.

Appiukko writes next door: Here is a recent interview where Optomed board member Leana Wen interviews CVS Health’s Chief Medical Officer, Amy Compton-Phillips.  The Beat Executive Video Series: Dr. Amy Compton-Phillips The Beat Executive Video Series: Dr. Amy Compton-Phillips  hlth.com

CVS Health’s Investor Day material is interesting reading. They will be an AI-native company going forward; it would be strange if they weren’t also that in diabetic retinopathy screening. Volume and resulting efficiency gains would be available at Minute Clinics and especially in Signify Health’s home visit business.            s206.q4cdn.com              2025-Investor-Day-Presentation.pdf    8.45 MB

An interesting article caught my eye, stating that oculomics is moving from research to practice. Oculomics is no longer just a single AI use case but an evolving care model. AEYE Health is positioning itself from an algorithmic solution to clinical infrastructure, and Optomed is one of the few physical platforms that enables oculomics scaling in primary healthcare. Together, these perfectly address payer pressure, the need for preventative care, and the 2026 healthcare transformation. Edit. The second part will be even more interesting. In Part Two of our Insight Media Oculomics series coming soon, we will look at how some vision care providers are already successfully putting oculomics into practice—and how this field represents an opportunity for growth.                   linkedin.com              Is Detecting Systemic Disease Through the Eye the Wave of the Future? |...    𝗜𝘀 𝗗𝗲𝘁𝗲𝗰𝘁𝗶𝗻𝗴 𝗦𝘆𝘀𝘁𝗲𝗺𝗶𝗰 𝗗𝗶𝘀𝗲𝗮𝘀𝗲 𝗧𝗵𝗿𝗼𝘂𝗴𝗵 𝘁𝗵𝗲 𝗘𝘆𝗲 𝘁𝗵𝗲 𝗪𝗮𝘃𝗲 𝗼𝗳 𝘁𝗵𝗲 𝗙𝘂𝘁𝘂𝗿𝗲? 𝖮𝖼𝗎𝗅𝗈𝗆𝗂𝖼𝗌 𝗂𝗌 𝗍𝗈𝖽𝖺𝗒’𝗌 𝖻𝗎𝗓𝗓𝗐𝗈𝗋𝖽, 𝖻𝗎𝗍 𝗂𝗌 𝗂𝗍 𝗁𝖾𝗋𝖾 𝗍𝗈 𝗌𝗍𝖺𝗒? 𝖨𝗇 𝗈𝗎𝗋 𝖯𝖺𝗋𝗍 𝖮𝗇𝖾 𝗈𝖿 𝗈𝗎𝗋 𝖮𝖼𝗎𝗅𝗈𝗆𝗂𝖼𝗌 𝗌𝖾𝗋𝗂𝖾𝗌, 𝗐𝖾 𝗎𝗇𝗉𝖺𝖼𝗄 𝖺 𝗉𝗋𝗂𝗆𝖾𝗋 𝗈𝗇 𝗍𝗁𝗂𝗌 𝖾𝗆𝖾𝗋𝗀𝗂𝗇𝗀 𝗉𝗋𝖺𝖼𝗍𝗂𝖼𝖾. 𝖨𝗇 𝖯𝖺𝗋𝗍 𝖳𝗐𝗈 𝖼𝗈𝗆𝗂𝗇𝗀 𝗌𝗈𝗈𝗇, 𝗐𝖾’𝗅𝗅 𝗅𝗈𝗈𝗄 𝖺𝗍...

Optomed

Optomed Plc Stock Exchange Release 26 November 2020 at 12.00, HelsinkiChange in Optomed's holding of treasuryA total of 35,500 of shares have been subscribed for under the Company's stock option...

Optomed Plc         Stock Exchange Release    26 November 2020 at 12.00, HelsinkiChange in Optomed's holding of treasuryA total of 35,500 of shares have been subscribed for under the Company's stock option plans 2009A, 2015, 2017B and 2018C and Optomed has used treasury shares for the share subscriptions. The subscribed shares have been delivered to the subscribers on 26 November 2020. The total amount of treasury shares is now 740,378.  Optomed PlcFurther enquiriesSakari Knuutti, CLO, Optomed Plc, <virtloc>sakari.knuutti@optomed.com</virtloc>Optomed in Brief Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld cameras with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye-diseases such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye-screening devices and software solutions related R&amp;D in Finland and sales through different channels in over 60 countries. The company has an extensive portfolio of 55 international patents protecting the technology. In 2019, Optomed's revenue reached EUR 15 million and at the end of 2019 Optomed employed 108 professionals.